Open AccessThe OECD Program to Validate the Rat Hershberger Bioassay to Screen Compounds for in Vivo Androgen and Antiandrogen Responses: Phase 2 Dose–Response Studies
Author(s) -
William Owens,
L. Earl Gray,
Errol Zeiger,
Michael P. Walker,
Kanji Yamasaki,
John Ashby,
Elard Jacob
Publication year - 2007
Publication title -
environmental health perspectives
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.257
H-Index - 282
eISSN - 1552-9924
pISSN - 0091-6765
DOI - 10.1289/ehp.9666
Subject(s) - antiandrogen , bioassay , in vivo , androgen , flutamide , biology , androgen receptor , chemistry , pharmacology , medicine , endocrinology , prostate cancer , hormone , genetics , cancer , microbiology and biotechnology
The Organisation for Economic Co-operation and Development (OECD) has completed phase 2 of an international program to validate the rodent Hershberger bioassay.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom